HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical antiandrogens in the treatment of male-pattern baldness.

Abstract
Antiandrogen therapy for androgen-induced baldness is in its infancy. In men, because of side effects, topical antiandrogens appear to hold the most promise. Assessing changes in scalp hair growth may be difficult, however, and hirsutism provides a useful model for testing the efficacy of topical antiandrogens. Systemic administration of 5 alpha-reductase inhibitors may also eventually prove to be helpful in the treatment of male-pattern baldness, but side effects and long-term risks are unknown. In women, systemic antiandrogens appear to be a reasonable option for therapy and produce a good subjective response. Further research is needed, however, to document the long-term risks and efficacy of systemic antiandrogen therapy in women.
AuthorsR S Rittmaster
JournalClinics in dermatology (Clin Dermatol) 1988 Oct-Dec Vol. 6 Issue 4 Pg. 122-8 ISSN: 0738-081X [Print] United States
PMID3063366 (Publication Type: Journal Article, Review)
Chemical References
  • Androgen Antagonists
  • Dihydrotestosterone
Topics
  • Administration, Topical
  • Alopecia (drug therapy, genetics)
  • Androgen Antagonists (administration & dosage, adverse effects, therapeutic use)
  • Animals
  • Dihydrotestosterone (metabolism)
  • Female
  • Hair (growth & development)
  • Hirsutism (drug therapy)
  • Humans
  • Macaca nemestrina
  • Male
  • Sex Characteristics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: